Tom1 Antibodies

Santa Cruz Biotechnology provides a broad selection of Tom1 Antibodies for research focused on understanding Tom1 protein functions. Tom1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tom1, or Target of Myb1, plays a key role in regulating endosomal trafficking and sorting ubiquitinated proteins. Tom1 maintains cellular homeostasis through its involvement in signal transduction and immune response pathways. Research has shown that Tom1 activity significantly influences the development and progression of cancer and neurodegenerative disorders. Scientists worldwide rely on Tom1 monoclonal antibodies to advance their understanding of cellular trafficking mechanisms. Ongoing studies of Tom1 continue to reveal new insights about its role in health and disease. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge about Tom1 and its biological significance.